Vantai

VantAI builds computational models that identify hidden links between molecules, targets, and diseases by combining the machine learning approach with deep systems biology expertise. From the deep analysis of systems-based pharmacogenomics, these models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME, and toxicological insights, and predicts adverse events likely to influence trial success. In addition to small-molecule therapeutics, VantAI's in silico platform excels in simulating complicated protein-protein interactions, enabling the discovery of biologics and protein degraders.

show less